The Roles of Icariin on the Proliferation and Apoptosis Abilities of Human Oophoroma Cells and Multi-drug Resistant Cell Line

JIANG Shao-yan, CHANG Hong, FAN Dan-yi, DENG Shao-jie

Abstract

To explore the effects of icariin on the proliferation and apoptosis abilities of human ovarian cancer cells SKOV3 and multi-drug resistant SKVCR cells. Methods Human ovarian cancer cells SKOV3 and multi-drug resistant SKVCR cells were treated with various concentrations of icariin. The inhibitory concentration and the half maximal inhibitory concentration were detected by CCK8 kit. The proliferation and apoptosis abilities of SKOV3 and SKVCR cells were measured by flow cytometry. The migration and invasion abilities of SKOV3 and SKVCR cells were evaluated by Transwell assays. The protein expression level of Caspase-3 was detected by Western blot analysis. Results Icariin significantly suppressed the proliferation abilities of SKOV3 and SKVCR cells in a dose-dependent manner at variant levels from 5-100 μg/mL. SKOV3 and SKVCR cells were treated with 19.5 μg/mL icariin and 48.4 μg/mL icariin (0.8×IC50) for 48 h, respectively. The results showed that the cell proliferation, migration and invasion abilities were markedly decreased comparing with control group, and the apoptosis rate was significantly increased as compared with control group (P<0.05). Western blot results indicated that icariin significantly increased the protein expression level of caspase-3 in SKOV3 and SKVCR cells (P<0.05). Conclusion Icariin suppressed the proliferation, migration and invasion abilities of human ovarian cancer cells. Increasing expression of Caspase-3 might be the mechanism of its enhancement of apoptosis.

 

Keywords: Oophoroma, Icariin, Cell proliferation, Apoptosis

 

Full Text:

PDF


References


CHEN M. WU J, LUO Q. et al. The anticancer properties of Herba Epimedii and its main bioactive componentsicariin and icariside II. Nutrients, 2016, 8 ( 9 ): 563 [ 2017-08-21 ] . http://www. mdpi. com/2072-6643/8/9/563 . doi; 10. 3390/ nu8090563.

LINDGREN PR, BACKSTROM T, CAJANDER S, et al. The pattern of estradiol and progesterone differs in serum and tissue of benign and malignant ovarian tumors. Int J Oncol, 2002,21(3):583-589.

LIU Y, HUANG L, HAO B, et al. Use of an osteoblast overload damage model to probe the effect of icariin on the proliferation, differentiation and mineralization of MC3T3-E1 cells through the wnt/beta-catenin signaling pathway. Cell Physiol Biochem, 2017,41 (4 ) ; 1605-1615.

WANG QS, WANG GF, ZHOU J, et al. Colon targeted oral drug delivery system based on chitosan/alginate microspheres loaded with icariin in the treatment of ulcerative colitis. Int J Pharm,2016,515(1/2): 176-185.

ZHANG DC. LIU JL, DING YB, et al. Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-kappaB. Acta Pharmacol Sin, 2013, 34 ( 2 ): 301-308.

LI J, JIANG K, ZHAO F. Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2. Oncol Rep,2015,33(6);2829-2836.

LIU H, LIU H, XIONG Y, et al. Icariin improves osteoporosis, inhibits the expression of PPARy, C/EBPa, FABP4 mRNA, N1ICD and jaggedl proteins, and increases Notch2 mRNA in ovariectomized rats. Exp Ther Med,2017, 13(4):1360-1368.


Refbacks

  • There are currently no refbacks.